Breast cancer is the most common cancer in women and like every cancer, there is a chance of breast cancer recurrence even after completion of the prescribed treatment. Hence, every woman has to ...

Researchers have identified ways in which chemotherapy can damage healthy cells and found that some drugs can add decades of ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

Welcome to our live blog covering the latest developments from across the continent. Follow real-time updates on political ...

For roughly 400 years, microscopes have allowed us to observe increasingly smaller details. Today's most advanced instruments ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with ...

Same mutations detected by the multicancer early detection test at index time point could be ID'd at 8.6- to 79-fold lower mutant allele fractions. (HealthDay News) — Circulating tumor DNA can ...

This method has been utilized to capture CTCs from the blood of patients with metastatic non-small-cell lung cancer, to perform EGFR mutational analysis on DNA recovered from these cells in order ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial information to make decisions about treatment. But more studies are needed ...

Government data projects nearly 620,000 cancer deaths in the U.S. this year. However, a new "Trojan horse" therapy could ...